Safety of Dostarlimab in Combination with Chemotherapy in Patients with Primary Advanced or Recurrent Endometrial Cancer in a Phase III, Randomized, Placebo-Controlled Trial (ENGOT-EN6-NSGO/GOG-3031/RUBY) Annika Auranen , Matthew A. Powell , Vladyslav Sukhin , Lisa M. Landrum , Graziana Ronzino , Joseph Buscema , Dirk Bauerschlag , Roy Lalisang , David Bender , Lucy Gilbert , Amy Armstrong , Tamar Safra , Nicole Nevadunsky , Alexandra Sebastianelli , Brian Slomovitz , Kari Ring , Robert Coleman , Iwona Podzielinski , Ashley Stuckey , Michael Teneriello , Sarah Gill , Bhavana Pothuri , Lyndsay Willmott , Sudarshan Sharma , Christine Dabrowski , Grace Antony , Shadi Stevens , Mansoor Raza Mirza , Evelyn Fleming THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY（2024）
关键词
dostarlimab, dostarlimab plus chemotherapy, endometrial cancer, immune checkpoint inhibitor, safety
AI 理解论文
溯源树
样例
